Erscheint 4 Ausgaben pro Jahr
ISSN Druckformat: 0893-9675
ISSN Online: 2162-6448
Indexed in
Genomic Pathology and Biomarkers in Breast Cancer
ABSTRAKT
Breast cancer is a highly heterogeneous disease. There are significant differences in morphology, immunophenotype, clinical behavior, and treatment response in breast cancer, which pose the greatest challenge for managing breast cancer patients. Great advances in breast cancer have been made at the molecular and genomic levels, which not only help us greatly in better understanding the heterogeneity and the carcinogenesis for breast cancer, but also help us in identifying new prognostic markers and therapeutic targets. In this review, we discuss these new findings in detail: (1) the two main pathways of the pathogenesis for breast cancer; (2) the traditional biomarkers including ER, PR, HER2, and some controversial biomarkers - Ki67, p53, AR, FRA for breast cancer; (3) the molecular classification of breast cancer, its IHC surrogates and its application in clinical management; (4) the multigene tests and their applications for breast cancer management; (5) next-generation sequencing and its clinical application for breast cancer; and (6) TIL and PD1/PD-L1 and their application in breast cancer.
-
Campos-Parra Alma, López-Urrutia Eduardo, Orozco Moreno Luz, López-Camarillo César, Meza-Menchaca Thuluz, Figueroa González Gabriela, Bustamante Montes Lilia, Pérez-Plasencia Carlos, Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer, International Journal of Molecular Sciences, 19, 9, 2018. Crossref
-
Agostinetto Elisa, Giordano Laura, Torrisi Rosalba, De Sanctis Rita, Masci Giovanna, Losurdo Agnese, Zuradelli Monica, Tinterri Corrado, Gatzemeier Wolfgang, Testori Alberto, Alloisio Marco, De Rose Fiorenza, Fernandes Bethania, Santoro Armando, Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer, Clinical Breast Cancer, 20, 4, 2020. Crossref
-
Gao Xiaoya, Huang Zifeng, Feng Cailing, Guan Chaohao, Li Ruidong, Xie Haiting, Chen Jian, Li Mingchun, Que Rongfang, Deng Bin, Cao Peihua, Li Mengyan, Lu Jianjun, Huang Yihong, Li Minzi, Yang Weihong, Yang Xiaohua, Wen Chunyan, Liang Xiaomei, Yang Qin, Chao Yin-Xia, Chan Ling-Ling, Yenari Midori A, Jin Kunlin, Chaudhuri K Ray, Zhang Jing, Tan Eng-King, Wang Qing, Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson’s disease, Briefings in Bioinformatics, 22, 4, 2021. Crossref
-
Dobre Elena-Georgiana, Dinescu Sorina, Costache Marieta, Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer, Cancers, 12, 9, 2020. Crossref
-
Cui Ranliang, Wang Chaomin, Li Tiantian, Hua Jialei, Zhao Ting, Ren Li, Wang Yichao, Li Yueguo, Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer, Cancer Cell International, 21, 1, 2021. Crossref
-
Höffken Verena, Hermann Anke, Pavenstädt Hermann, Kremerskothen Joachim, WWC Proteins: Important Regulators of Hippo Signaling in Cancer, Cancers, 13, 2, 2021. Crossref
-
Bueno Adriana Passos, Palu Rafael Felipe, Dalcin José Francisco, Moraes Lucas Neves, Silva Eveline Cristina, Novaes Silva Tulio, Saieg Mauro Ajaj, Accuracy of fine‐needle aspiration of lymph nodes: A cancer center’s experience, Cytopathology, 33, 1, 2022. Crossref
-
Dobovišek Luka, Novak Metka, Krstanović Fran, Borštnar Simona, Turnšek Tamara Lah, Debeljak Nataša, Effect of combining CBD with standard breast cancer therapeutics, Advances in Cancer Biology - Metastasis, 4, 2022. Crossref